Recently, a differential expression of ABCC11 (MRP8) mRNA has been demonstrated in AML blasts from 50 patients, together with a low probability of overall survival at 4 years for those with high expression of MRP8. This evidence concerns the gene ABCC11 and acute myeloid leukemia.